Zacks Investment Research cut shares of VCA Inc. (NASDAQ:WOOF) from a buy rating to a hold rating in a report issued on Wednesday morning.
According to Zacks, “VCA Inc. is a national animal healthcare company operating primarily in the United States and Canada. It owns, operates and manages veterinary hospitals and veterinary-exclusive clinical laboratories in the country, supplies diagnostic imaging equipment and other medical technology products and related services to the veterinary industry, and provides various communication, professional education and marketing solutions to the veterinary community. VCA Inc., formerly known as VCA Antech, Inc., is headquartered in Los Angeles, California. “
WOOF has been the topic of a number of other research reports. BidaskClub upgraded shares of VCA from a buy rating to a strong-buy rating in a report on Thursday, June 29th. Stifel Nicolaus restated a hold rating and issued a $93.00 price objective on shares of VCA in a report on Friday, July 14th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the company. VCA presently has an average rating of Hold and an average target price of $92.17.
VCA (NASDAQ:WOOF) opened at 92.98 on Wednesday. The firm’s 50-day moving average price is $92.72 and its 200-day moving average price is $92.11. The firm has a market cap of $7.56 billion, a P/E ratio of 34.94 and a beta of 1.01. VCA has a 1-year low of $59.51 and a 1-year high of $93.00.
VCA (NASDAQ:WOOF) last announced its quarterly earnings data on Wednesday, July 26th. The company reported $0.96 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.94 by $0.02. The business had revenue of $743.13 million for the quarter, compared to analysts’ expectations of $735.75 million. VCA had a net margin of 8.00% and a return on equity of 15.54%. During the same quarter in the prior year, the company earned $0.87 earnings per share. Equities research analysts anticipate that VCA will post $3.23 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at https://www.chaffeybreeze.com/2017/09/16/vca-inc-woof-downgraded-by-zacks-investment-research.html.
Large investors have recently bought and sold shares of the company. Meeder Asset Management Inc. purchased a new stake in shares of VCA during the first quarter valued at approximately $163,000. Advisory Services Network LLC grew its holdings in shares of VCA by 1.1% during the second quarter. Advisory Services Network LLC now owns 1,957 shares of the company’s stock valued at $181,000 after buying an additional 22 shares during the last quarter. RBF Capital LLC purchased a new stake in shares of VCA during the first quarter valued at approximately $201,000. Daiwa Securities Group Inc. purchased a new stake in shares of VCA during the second quarter valued at approximately $217,000. Finally, CNA Financial Corp purchased a new stake in shares of VCA during the first quarter valued at approximately $238,000. Hedge funds and other institutional investors own 76.52% of the company’s stock.
VCA Company Profile
VCA Inc is an animal healthcare company operating in the United States and Canada. The Company operates through five segments: animal hospitals (Animal Hospital), veterinary diagnostic laboratories (Laboratory), veterinary medical technology (Medical Technology), Vetstreet and Camp Bow Wow Franchising, Inc (Camp Bow Wow).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for VCA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VCA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.